The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
for the propyl series can be used for extrapolation <strong>of</strong> results <strong>of</strong> rat toxicology studies<br />
(e.g., no-observed adverse effect levels) to human-equivalent values for exposure to<br />
propyl acetate or propanol.<br />
2295 USING MARGINS OF EXPOSURE AS A SEGREGATION<br />
TOOL FOR RISK ASSESSMENT OF TOBACCO SMOKE<br />
TOXICANTS.<br />
S. Fiebelkorn, F. H. Cunningham and C. Meredith. Group R&D, British<br />
American Tobacco, Southampton, United Kingdom.<br />
Identification <strong>of</strong> tobacco smoke toxicants has received significant attention during<br />
recent years. Key examples include establishment <strong>of</strong> the World Health<br />
Organisation (WHO) Study Group on Tobacco Product Regulation (TobReg) and<br />
most recently, in 2009, the Family Smoking Prevention and Tobacco Control Act.<br />
<strong>The</strong>re is a clear focus to develop lists <strong>of</strong> tobacco toxicants which may guide proposal<br />
<strong>of</strong> limits, recommendations for lowering and/or routine monitoring. We suggest<br />
development <strong>of</strong> a quantitative risk assessment paradigm, using multiple assessment<br />
techniques to estimate the contribution <strong>of</strong> individual toxicants to smoking-related<br />
diseases, with the aim <strong>of</strong> establishing priorities for risk reduction research. As an initial<br />
model, we propose adoption <strong>of</strong> the Margins <strong>of</strong> Exposure (MOE) model, following<br />
European Food Safety Authority (EFSA) guidelines. An MOE is a ratio between<br />
a benchmark dose (derived from existing toxicological dose-response data)<br />
and estimated human exposure. Compounds with computed MOEs >10,000 are<br />
considered to be “low priority for risk management actions”. Our approach is to<br />
calculate MOE values for individual tobacco smoke toxicants from a range <strong>of</strong> published<br />
toxicity studies and from published data on yields from machine smoking to<br />
determine consistency within available data sets. Computed MOEs enable segregation<br />
<strong>of</strong> toxicants into high and low priority groupings for risk reduction research<br />
depending on their relationship to the critical MOE value <strong>of</strong> 10,000. For example,<br />
following this procedure, carcinogenicity data sets for 1,3-Butadiene yield MOEs<br />
all below 10,000 whereas MOEs for vinyl chloride are all above 10,000. Using noncancer<br />
end-points for cresol(s) yields MOEs that are all above 10,000. We propose<br />
that estimation <strong>of</strong> MOEs for smoke toxicants is a useful first step towards prioritisation<br />
<strong>of</strong> toxicants for risk reduction research. Future developments will invoke<br />
more complex, but physiologically more relevant paradigms, such as physiologically-based<br />
pharmacokinetic (PBPK) modelling to ascertain the importance <strong>of</strong> a<br />
toxicant to smoking-related diseases.<br />
2296 USE OF CONTROL BANDING AND SENSORY<br />
IRRITATION (RD 50 ) DATA TO ASSESS OCCUPATIONAL<br />
EXPOSURE VALUES FOR N-PROPYL, N-BUTYL, AND<br />
N-PENTYL PROPIONATE.<br />
S. M. Krieger 1 , D. R. Geter 1 , T. J. Cawley 1 , M. Osterloh-Quiroz 2 and J. A.<br />
Hotchkiss 1 . 1 <strong>The</strong> Dow Chemical Company, Midland, MI and 2 Dow Europe GmbH,<br />
Horgen, Switzerland.<br />
N-propyl, n-butyl, and n-pentyl propionate are colorless liquid chemical intermediates<br />
used in the production <strong>of</strong> pharmaceuticals, anti-fungal agents, agrochemicals,<br />
plastics, plasticizers, rubber chemicals, dyes, artificial flavors, and synthetic<br />
perfumes. In addition, they are used as solvents in low VOC coating formulations.<br />
Inhalation is the primary route <strong>of</strong> potential occupational exposure to these materials.<br />
No occupational threshold limit values (TLV) are currently established for this<br />
solvent family. Atrophy, degeneration and necrosis <strong>of</strong> the olfactory epithelium are<br />
the most sensitive repeat inhalation observations <strong>of</strong> the above mentioned propionates.<br />
Inhalation No-Observed-Effect Concentrations (NOEC) range from 50-<br />
500 and 50-750 ppm for subacute and subchronic toxicity, respectively; 500-2000<br />
ppm for reproductive and developmental toxicity, and 500-3200 ppm for neurotoxicity.<br />
A control banding (matrix) approach may be used to identify a range <strong>of</strong><br />
permissible occupational exposure concentrations. Based on the available repeat inhalation-exposure<br />
data, TLVs in the range <strong>of</strong> 1-10 ppm for nasal toxicity and 10-<br />
100 ppm for systemic toxicity were derived. Perceived irritation <strong>of</strong> the nose, throat<br />
and eyes is recognized as a critical effect and <strong>of</strong>ten used to derive TLVs. <strong>The</strong> TLV<br />
for many irritant chemicals falls within a range 0.01 - 0.1 RD 50 , with 0.03 <strong>of</strong>ten<br />
used as the appropriate value (RD 50 = concentration causing a 50% reduction in<br />
baseline respiration rate). We experimentally established RD 50 values <strong>of</strong> 535 and<br />
668 ppm for n-propyl and n-butyl propionate, respectively (ASTM Method E 981-<br />
04). Calculated TLVs based on 0.03 times the RD 50 yielded values <strong>of</strong> 16.1 and 20.0<br />
ppm for n-propyl- and n-butyl propionate, respectively. <strong>The</strong>se values are in agreement<br />
with the repeat inhalation derived TLVs and support the use <strong>of</strong> RD 50 in calculating<br />
these data.<br />
2297 ASSESSING NON-CANCER HEALTH RISK FROM<br />
INHALED PCBS.<br />
G. M. Lehmann 1 and J. Schaum 2 . 1 ORD, U.S. EPA, Research Triangle Park, NC<br />
and 2 ORD, U.S. EPA, Washington, DC.<br />
Exposure to polychlorinated biphenyls (PCBs) has been associated with adverse<br />
health effects in humans, including hepatotoxicity, altered thyroid hormone homeostasis,<br />
immunotoxicity, reproductive effects, and developmental neurobehavioral<br />
toxicity. Contaminated food consumption has historically been the major contributor<br />
to PCB body burden, but contamination <strong>of</strong> indoor air may also contribute in<br />
some exposure scenarios. Although chronic oral reference values have been derived<br />
for PCBs, derivation <strong>of</strong> inhalation values is challenging due to a pr<strong>of</strong>ound lack <strong>of</strong><br />
data. Dosimetric adjustments are sometimes applied to use oral reference values as a<br />
basis for derivation <strong>of</strong> inhalation reference values. Such route-to-route extrapolation<br />
introduces uncertainty into human health risk analysis, as it requires certain<br />
basic assumptions in order to establish similarity between the oral and inhalation<br />
routes. With PCBs, further uncertainty results from differences between oral and<br />
inhalation exposures unique to this chemical class. <strong>The</strong>se differences occur because<br />
PCBs are chemical mixtures made up <strong>of</strong> a variety <strong>of</strong> individual congeners. <strong>The</strong> degree<br />
<strong>of</strong> congener chlorination in a PCB mixture is an important determinant <strong>of</strong> the<br />
mixture’s physicochemical properties and toxicity. Volatile congeners tend to be less<br />
chlorinated, less persistent, and less toxic than those found in food. Chronic oral<br />
reference values are currently available for two PCB mixtures: Aroclors 1016 and<br />
1254. Aroclor 1016 contains lower-chlorinated PCB congeners than Aroclor 1254.<br />
Because inhalation exposure favors lower-chlorinated PCB congeners, the Aroclor<br />
1016 reference value may be more representative than the Aroclor 1254 value for<br />
assessment <strong>of</strong> inhalation exposure risk. However, uncertainties remain regarding the<br />
relative toxicities <strong>of</strong> these PCB mixtures and the application <strong>of</strong> their oral reference<br />
values to inhalation exposure risk. This presentation will explore these uncertainties<br />
and identify critical areas <strong>of</strong> research needed to improve risk estimation for inhaled<br />
PCBs. <strong>The</strong> views expressed here do not reflect the views or policies <strong>of</strong> the U.S. EPA.<br />
2298 STRUCTURE-ACTIVITY MODELS FOR CHEMICAL<br />
INHALATION HEALTH GUIDANCE VALUES.<br />
C. J. Collar 1 , T. Miller 2 , R. M. Garrett 2 and E. Demchuk 1 . 1 Division <strong>of</strong><br />
<strong>Toxicology</strong> and Environmental Medicine, ATSDR/CDC, Atlanta, GA and<br />
2 Department <strong>of</strong> Defense, Washington, DC. Sponsor: B. Fowler.<br />
Acute Exposure Guideline Levels (AEGLs) are thoroughly examined data for airborne<br />
concentrations <strong>of</strong> hazardous chemicals. <strong>The</strong>se chemical concentrations are<br />
defined as the human threshold limits at five exposure periods ranging from ten<br />
minutes to eight hours. Health effects are categorized by the National Academy <strong>of</strong><br />
Sciences (NAS) as non-disabling (AEGL-1), disabling (AEGL-2), and lethal<br />
(AEGL-3). However, AEGLs are finalized for less than sixty compounds, and less<br />
than two-hundred are considered interim; far less than the number <strong>of</strong> potential airborne<br />
hazards to the human population. We employed the AEGLs data at the eight<br />
hour exposure period, to construct quantitative structure-activity relationship<br />
(QSAR) models capable <strong>of</strong> predicting provisional health guidance values (HGVs)<br />
for airborne chemical hazards that have no guidance assigned by the NAS. <strong>The</strong>se<br />
models are statistically significant with R 2 and Q 2 values greater than 0.70 and<br />
0.50, respectively. Since QSAR modeling is driven by uniformity and quantity <strong>of</strong><br />
underlying data, point-<strong>of</strong>-departure and endpoint grouping factors can be employed<br />
to gain insight into how the model is formulating HGV estimates and what<br />
can be done to increase the estimation performance. Hence, we have begun this<br />
process by assessing the point-<strong>of</strong>-departure information. <strong>The</strong> AEGLs datasets were<br />
split into subsets <strong>of</strong> human and rat data and new models were built. With statistical<br />
significance comparable or better than parent models, these species-specific models<br />
were individually analyzed and also employed to validate each other; the compounds<br />
<strong>of</strong> the first model were used as a testing dataset for the second model and<br />
vice versa. In the future we plan to: (1) employ additional endpoint grouping factors,<br />
(2) model the remaining four time periods, and (3) incorporate other HGVs<br />
into the models.<br />
2299 THORACIC DAMPING AND THE RELATIONSHIP<br />
BETWEEN PENH OF THE THORACIC AIR-FLOW (I T )<br />
AND TIDAL MIDEXPIRATORY FLOW (EF 50 ).<br />
D. G. Frazer, J. S. Reynolds, W. T. Goldsmith, W. G. McKinney, M. C. Jackson<br />
and A. A. Afshari. HELD, CDC / NIOSH, Morgantown, WV. Sponsor: A. Hubbs.<br />
<strong>The</strong> thoracic air-flow pattern can be modeled as a response to the action <strong>of</strong> the respiratory<br />
muscles. That response can be viewed as being either under-damped, when<br />
I T is initially higher then decays toward the end <strong>of</strong> exhalation, or damped when I T<br />
is initially lower and then rises toward the end <strong>of</strong> exhalation. Both Penh(I T ) and the<br />
SOT 2011 ANNUAL MEETING 493